Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 31, 2022

SELL
$6.37 - $15.23 $440,122 - $1.05 Million
-69,093 Reduced 6.68%
964,759 $14.6 Million
Q2 2022

Aug 02, 2022

BUY
$4.95 - $9.16 $13,795 - $25,528
2,787 Added 0.27%
1,033,852 $7.75 Million
Q1 2022

May 05, 2022

BUY
$5.64 - $9.8 $1.64 Million - $2.85 Million
290,802 Added 39.28%
1,031,065 $9.38 Million
Q4 2021

Feb 02, 2022

BUY
$7.02 - $13.33 $350,887 - $666,286
49,984 Added 7.24%
740,263 $5.2 Million
Q3 2021

Oct 19, 2021

SELL
$11.32 - $16.63 $78,391 - $115,162
-6,925 Reduced 0.99%
690,279 $7.87 Million
Q2 2021

Aug 02, 2021

BUY
$15.16 - $18.97 $132,149 - $165,361
8,717 Added 1.27%
697,204 $11.2 Million
Q1 2021

May 12, 2021

SELL
$13.12 - $20.9 $757,155 - $1.21 Million
-57,710 Reduced 7.73%
688,487 $12.3 Million
Q4 2020

Jan 26, 2021

BUY
$9.12 - $14.49 $2.03 Million - $3.22 Million
222,137 Added 42.39%
746,197 $10.1 Million
Q3 2020

Oct 23, 2020

SELL
$10.46 - $14.46 $137,130 - $189,570
-13,110 Reduced 2.44%
524,060 $6.17 Million
Q2 2020

Aug 14, 2020

BUY
$12.0 - $16.13 $1.41 Million - $1.89 Million
117,447 Added 27.98%
537,170 $7.93 Million
Q1 2020

May 13, 2020

SELL
$11.84 - $25.52 $602,679 - $1.3 Million
-50,902 Reduced 10.82%
419,723 $5.67 Million
Q4 2019

Feb 03, 2020

BUY
$17.72 - $25.1 $281,305 - $398,462
15,875 Added 3.49%
470,625 $11.4 Million
Q3 2019

Nov 08, 2019

BUY
$18.41 - $28.0 $8.37 Million - $12.7 Million
454,750 New
454,750 $8.74 Million

Others Institutions Holding AERI

About AERIE PHARMACEUTICALS INC


  • Ticker AERI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,390,500
  • Description
  • Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...
More about AERI
Track This Portfolio

Track Pinnacle Associates LTD Portfolio

Follow Pinnacle Associates LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinnacle Associates LTD, based on Form 13F filings with the SEC.

News

Stay updated on Pinnacle Associates LTD with notifications on news.